The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Open accessAbstract
Objective The presence of T cells within the epithelial component of tumors, as histologic evidence of anti-tumor immunity, has been associated with a survival advantage in multiple studies across diverse patient cohorts. We performed a meta-analysis of studies evaluating the prognostic value of tumor-infiltrating lymphocytes (TIL) on survival among women with ovarian cancer and to investigate factors associated with variations in this effect, including patient characteristics, surgical outcomes, tumor histology, and study protocols. Method Published studies that evaluated the association between TIL and patient survival were identified. Descriptive statistics, outcome data, and study quality were extracted from studies that met inclusion criteria. Hazard ratios and 95% confidence intervals were pooled across studies using the random-effects model. Publication bias was investigated using a funnel plot and heterogeneity was assessed with subgroup analysis and I2 statistics. Results Ten suitable studies comprising 1,815 patients with ovarian cancer were analyzed. Our results demonstrate that a lack of intraepithelial TILs is significantly associated with a worse survival among patients (pooled HR: 2.24, 95% CI; 1.71–2.91). Variations in the prognostic value of TIL status based on debulking status, scoring method, and geographic regions were identified. Conclusions Intraepithelial TILs are a robust predictor of outcome in ovarian cancer and define a specific class of patients, whose distinct tumor biology should be taken into account in devising appropriate therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Self-citationSato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611533104 · Cited by 1,378
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Winter, W. E., Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., Markman, M., Armstrong, D. K., Muggia, F., & McGuire, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2517 · Cited by 845
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 756
Hoskins, W. J., McGuire, W. P., Brady, M. F., Homesley, H. D., Creasman, W. T., Berman, M., Ball, H., & Berek, J. S. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70090-7 · Cited by 659
Chi, D. S., Eisenhauer, E. L., Lang, J., Huh, J., Haddad, L., Abu-Rustum, N. R., Sonoda, Y., Levine, D. A., Hensley, M., & Barakat, R. R. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.051 · Cited by 634
(1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)90219-8 · Cited by 553
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 446
Leffers, N., Gooden, M. J. M., de Jong, R. A., Hoogeboom, B.-N., ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G. J., Daemen, T., & Nijman, H. W. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0583-5 · Cited by 402
Clarke, B., Tinker, A. V., Lee, C.-H., Subramanian, S., van de Rijn, M., Turbin, D., Kalloger, S., Han, G., Ceballos, K., Cadungog, M. G., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.191 · Cited by 280
Self-citationPrognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Tomšová, M., Melichar, B., Sedláková, I., & Šteiner, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.016 · Cited by 186
Eisenhauer, E. L., Abu-Rustum, N. R., Sonoda, Y., Aghajanian, C., Barakat, R. R., & Chi, D. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.022 · Cited by 178
The impact of T‐cell immunity on ovarian cancer outcomes
Nelson, B. H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00614.x · Cited by 172
Immunotherapy for Ovarian Cancer: What's Next?
Kandalaft, L. E., Powell, D. J., Singh, N., & Coukos, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2369 · Cited by 164
Self-citationHan, L. Y., Fletcher, M. S., Urbauer, D. L., Müeller, P. R., Landen, C. N., Kamat, A. A., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Deavers, M. T., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4433 · Cited by 153
Callahan, M. J., Nagymányoki, Z., Bonome, T., Johnson, M. E., Litkouhi, B., Sullivan, E. H., Hirsch, M. S., Matulonis, U. A., Liu, J. F., Birrer, M. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0479 · Cited by 143
Intraepithelial T cells and tumor proliferation
Adams, S. F., Levine, D. A., Cadungog, M. G., Hammond, R., Facciabene, A., Olvera, N., Rubin, S. C., Boyd, J. A., Gimotty, P. A., & Coukos, G. (2009) · Cancer · doi:10.1002/cncr.24317 · Cited by 121
Self-citationStumpf, M., Hasenburg, A., Riener, M. O., Jütting, U., Wang, C., Shen, Y., Orlowska‐Volk, M., Fisch, P., Wang, Z., Gitsch, G., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605274 · Cited by 115
Shah, C., Allison, K. H., Garcia, R. L., Gray, H. J., Goff, B. A., & Swisher, E. M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.010 · Cited by 84
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Alagkiozidis, I., Facciabene, A., Tsiatas, M. L., Carpenito, C., Benencia, F., Adams, S. F., Jonak, Z., June, C. H., Powell, D. J., & Coukos, G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-77 · Cited by 64
Self-citationDadmarz, R., Ordoubadi, A., Mixon, A., Thompson, C. O., Barracchini, K. C., Hijazi, Y. M., Steller, M. A., Rosenberg, S. A., & Schwartzentruber, D. J. (1996) · PubMed · Cited by 54
Alagkiozidis, I., Facciabene, A., Carpenito, C., Benencia, F., Jonak, Z., Adams, S. F., Carroll, R. G., Gimotty, P. A., Hammond, R., Danet-Desnoyers, G., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-104 · Cited by 50
Self-citationTumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer
Milne, K., Barnes, R. O., Girardin, A., Mawer, M. A., Nesslinger, N. J., Ng, A. V., Nielsen, J. S., Sahota, R. A., Tran, E., Webb, J. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003409 · Cited by 43
Kooi, S., Rs, F., Rodríguez‐Villanueva, J., & Platsoucas, C. D. (1993) · PubMed · Cited by 43
Kandalaft, L. E., Singh, N., Liao, J. B., Facciabene, A., Berek, J. S., Powell, D. J., & Coukos, G. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.11.001 · Cited by 39
Self-citationStudy of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer
Tsiatas, M. L., Gyftaki, R., Liacos, C., Politi, E., Rodolakis, A., Dimopoulos, M. A., & Bamias, A. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181b7a40e · Cited by 39
Hayashi, K., 与那嶺, 京., Masuko, K., Iida, T., Yamamoto, K., Nishioka, K., & Kato, T. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5430 · Cited by 37
Halapi, E. C., Yamamoto, Y., Juhlin, C., Jeddi‐Tehrani, M., Grünewald, J., Andersson, R., Hising, C., Masucci, G. V., Mellstedt, H., & Kiessling, R. W. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741091 · Cited by 31
Cited by
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
Lheureux, S., Gourley, C., Vergote, I., & Oza, A. M. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32552-2 · Cited by 1,919
Matulonis, U. A., Sood, A. K., Fallowfield, L., Howitt, B. E., Sehouli, J., & Karlan, B. Y. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.61 · Cited by 1,362
Hamanishi, J., Mandai, M., Ikeda, T., Minami, M., Kawaguchi, A., Murayama, T., Kanai, M., Mori, Y., Matsumoto, S., Chikuma, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.3397 · Cited by 1,180
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Motz, G. T., Santoro, S. P., Wang, L.-P., Garrabrant, T., Lastra, R. R., Hagemann, I. S., Lal, P., Feldman, M. D., Benencia, F., & Coukos, G. (2014) · Nature Medicine · doi:10.1038/nm.3541 · Cited by 1,035
Self-citation
Metadata
- Authors
- Hwang, W.-T., Adams, S. F., Tahirovic, E., Hagemann, I. S., & Coukos, G.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 124
- Issue
- 2
- Pages
- 192-198
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2027726380
- Cited by
- 661
- References
- 36
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.